Skip to main content

Advertisement

Log in

A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer

  • Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

CLIC5 encoded protein associates with actin-based cytoskeletal and is increasingly thought to play significant roles in human cancers. We use TCGA and GEO to explore CLIC5 expression differences, mutation and DNA methylation, TMB, MSI, and immune cell infiltration. We verified the mRNA expression of CLIC5 in human ovarian cancer cells by real-time PCR and detected the expression of CLIC5 as well as immune marker genes in ovarian cancer by immunohistochemistry. The pan-cancer analysis showed that CLIC5 is highly expressed in several malignant tumors. In some cancers, CLIC5 expression in tumor samples is associated with poorer overall survival. For example, patients with ovarian cancer with high expression of CLIC5 have a poor prognosis. CLIC5 mutation frequency increased in all tumor types. The CLIC5 promoter is hypomethylated in most tumors. CLIC5 was associated with tumor immunity and different immune cells of different tumor types, such as CD8 + T cells, tumor-associated fibroblasts, macrophages, etc. CLIC5 was positively correlated with various immune checkpoints, and TMB and MSI were correlated with dysregulation of CLIC5 in tumors. The expression of CLIC5 in ovarian cancer was detected by qPCR and IHC, and the results were consistent with the bioinformatics results. There were a strong positive correlation between CLIC5 expression and M2 macrophage (CD163) infiltration and a negative correlation with CD8 + T-cell infiltration. In conclusions, our first pan-cancer analysis offered a detailed grasp of the cancerogenic functions of CLIC5 in a variety of malignancies. CLIC5 participated in immunomodulation and performed a crucial function in the tumor microenvironment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

Data availability

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/supplementary material.

Abbreviations

ACC:

Adrenocortical carcinoma

BLCA:

Bladder urothelial carcinoma

BRCA:

Breast invasive carcinoma

CLIC5:

Chloride intracellular channel protein 5

CHOL:

Cholangiocarcinoma

COAD:

Colon adenocarcinoma

CESC:

Cervical squamous cell carcinoma

DLBC:

Diffuse large B-cell lymphoma

DSS:

Disease-specific survival

ERM:

Ezrin, radixin, and moesin

ESCA:

Esophageal carcinoma

GTEx:

Genotype-tissue expression

GBM:

Glioblastoma multiforme

GEO:

Gene expression omnibus

GEPIA:

Gene expression profiling interactive analysis

HNSC:

Head and neck squamous cell carcinoma

KICH:

Kidney chromophobe

KIRC:

Kidney renal clear cell carcinoma

KIRP:

Kidney renal papillary cell carcinoma;

LAML:

Acute myeloid leukemia

LGG:

Brain lower grade glioma

LIHC:

Liver hepatocellular carcinoma

LUAD:

Lung adenocarcinoma

LUSC:

Lung squamous cell carcinoma

MSI:

Microsatellite instability

MESO:

Mesothelioma

OS:

Overall survival

OV:

Ovarian cancer

PFI:

Progression-free interval

PRAD:

Prostate adenocarcinoma

PCPG:

Pheochromocytoma and paraganglioma

READ:

Rectum adenocarcinoma

SKCM:

Skin cutaneous melanoma

SARC:

Sarcoma

STAD:

Stomach adenocarcinoma

TCGA:

The cancer genome atlas

TIMER:

Tumor immune estimation resource

THCA:

Thyroid carcinoma

THYM:

Thymoma

TME:

Tumor microenvironment

TMB:

Tumor mutation burden

TPM:

Transcripts per million

UCEC:

Uterine corpus endometrial carcinoma.

UVM:

Uveal melanoma

UCS:

Uterine carcinosarcoma

References

Download references

Acknowledgements

The authors would like to thank all of the authors listed in this manuscript.

Funding

This work was supported by grants from National Natural Science Foundation of China, the Natural Science Foundation of China (81172537, 81272900, 81772828), and the 2021 Clinical Research Project of the Second Affiliated Hospital of Guangzhou Medical University (2021-LCYJ-03).

Author information

Authors and Affiliations

Authors

Contributions

JC and GX designed the study. MH, JH, and HW collected the literature. QL, CH, JC, and QH analyzed the data. QH, WT, and YX drafted the manuscript. YP, GX, and HL modified the manuscript. All authors contributed to the article and approved the submitted version.

Corresponding authors

Correspondence to Jingqi Chen or Guohong Xiao.

Ethics declarations

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethical approval

This study was approved by the Clinical Research and Application Ethics Committee, The Second Hospital of Guangzhou Medical University, Guangzhou, China, and written informed consent was obtained from all donors. The survey was conducted in accordance with the principles of the Declaration of Helsinki. In addition, all the datasets were collected from the publishing literature, so all written informed consent was obtained. Consent for publication of all case reports has been obtained from the individual.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 806 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, Q., Lv, Q., Tang, W. et al. A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer. J Cancer Res Clin Oncol 149, 10561–10583 (2023). https://doi.org/10.1007/s00432-023-04927-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-023-04927-4

Keywords

Navigation